Frequently Asked Questions
Create Your Account Now and Start Posting Resumes and/or Jobs
Create/Edit Your Resume
Search Jobs
Post Jobs, Search Resumes

1623 Posted Jobs
This page is developed
and maintained by the
Rollins School of Public Health.
Rollins Distance Learning

Job Title: FDA In Vitro and In Vivo Bioequivalence Fellowship
Job Number:
Organization: US Food and Drug Administration (FDA)
Posted: 1/9/2022
Type: Full-Time
Number of Openings: 1
Location: Silver Spring,  MD    USA
Position Description: *Applications will be reviewed on a rolling- basis.

Research opportunities are available in the Office of Generic Drugs/ Office of Research and Standards (ORS), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) in multiple locations such as Jefferson, Arkansas, St. Louis, Missouri, Silver Spring, Maryland, or a variety of different laboratories. CDER performs an essential public health task by making sure that safe and effective drugs are available to improve the health of people in the United States. As part of the FDA, CDER regulates over-the-counter and prescription drugs, including biological therapeutics and generic drugs. This work covers more than just medicines.

This research project seeks to identify and develop proposals for novel in vitro, in vivo, or in silico techniques that may be capable of determining whether various complexity factors related to generic drug products will impact their bioequivalence with their reference products. These factors may include complex drug substances and formulations, as well as device-related considerations capable of impacting product performance and bioequivalence. Specific research may also involve relevant human factors research and human pharmacokinetics (PK) or clinical endpoint studies.

Under the guidance of the mentor, the participant will gain a comprehensive understanding of the scientific and regulatory challenges that must be considered when establishing bioequivalence for complex drug products including drug suspensions, long-acting polymer-based drugs, oral inhaled and nasal products, topical and transdermal drugs, and combination drug-device products with device components that may themselves have degrees of complexity in design. In addition, the participant will gain knowledge in collaborating with cross-disciplinary teams to develop novel in vitro, in vivo, and/or in silico study designs for establishing bioequivalence with these products.

This program, administered by ORAU through its contract with the U.S. Department of Energy to manage the Oak Ridge Institute for Science and Education, was established through an interagency agreement between DOE and FDA. The initial appointment is for one year, but may be renewed upon recommendation of FDA contingent on the availability of funds. The participant will receive a monthly stipend commensurate with educational level and experience. Proof of health insurance is required for participation in this program. The appointment is full-time at FDA in multiple laboratory areas. Participants do not become employees of FDA, DOE or the program administrator, and there are no employment-related benefits.

Qualifications: The qualified candidate should be currently pursuing or have received a master's or doctoral degree in one of the relevant fields. Degree must have been received within five years of the appointment start date.

Organization Description:

Closing Date: 4/9/2022
Desired Starting Date:
Contact Name: N/A N/A,  FDA In Vitro and In Vivo Bioequivalence Fellowship
Contact Location:

Contact Location:
Contact Phone:  
Contact Fax:
Contact Email:
Web Address:
How to Apply: Applications must be completed in Zintellect at the Web Address provided.

Additional Information:

Web Site Delete Date: 4/9/2022